ClinicalTrials.gg
CompletedNCT05397964Updated Nov 5, 2026

Retrospective Evaluation of the Results of Direct Pulp Capping Treatment

An observational study in Pulp Exposure, Dental, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by Istanbul Medipol University Hospital · Observational

How we know

Updated Nov 5, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
190
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The aim of this retrospective study is to evaluate the vitality of teeth that had been treated with calcium hydroxide in direct pulp capping cases.

Read the detailed description

During restorative procedures, pulp tissue may be exposed while caries is removed from deep dentin tissue. There are some defense mechanisms to protect against bacterial invasion, but the best barrier is provided by living pulp tissue. During the life of a tooth, living pulp tissue is responsible for the formation of secondary dentin, peritubular dentin, and repair dentin in response to biological or pathological stimuli. Direct pulp capping means closing the exposed pulp tissue with the aim of healing. Calcium hydroxide, a biocompatible material, has been used for many years in pulp capping, with its ability to reduce bacterial infection and promote dentinopulpal remineralization. However, the results regarding the long-term clinical success of direct pulp capping with calcium hydroxide are conflicting. After the calcium hydroxide application, the restoration should be done with a filling material that can prevent the bacteria transfer between the restoration and the tooth tissue in the long term. The success of the restoration has a significant impact on the healing and treatment outcome. The aim of this study is to evaluate the clinical success of 217 direct capping treatments and restorations ,which were routinely applied to 190 patients in our clinic between 2011 and 2020.

Individuals who were invited to the control session and approved to participate in the research with their signatures, to evaluate the result of direct capping treatment, will be examined by:

  • Visual examination: Related teeth and soft tissue will be examined.
  • Palpation: The apex of the related tooth will be palpated intra and extra orally.
  • Percussion: Percussion will be performed on the related tooth horizontally and vertically with a handpiece.
  • Cold test: Ethyl chloride (Chloraethyl, IGS AEROSOLS GMBH, Baden, Germany) cold spray is applied to a small cotton pellet to the symmetrical tooth, which is thought to be alive, for control purposes, and then to the cervical 1/3 of the relevant tooth for 2-3 seconds.Sensitivity will be asked. A sensitive tooth will be considered to have responded positively to the cold test. In the absence of sensitivity, the tooth will be considered to have given a negative response.
  • Electric pulp test: For control purposes, first the symmetrical tooth, which is thought to be alive, and then the related tooth will be tested with the Digitest Pulp Vitality Tester (Parkell, INC., New York, USA). Before the test, the teeth will be isolated from saliva with a cotton pad and toothpaste will be used as a conductive. During the application, the patient will be asked whether she/he has sensitivity. In case of sensitivity, the tooth will be deemed to have responded positively to the electrical pulp test and the relevant value will be recorded .If there is no sensitivity, the answer will be accepted as negative.
  • Radiographic examination: If swelling, fistula, inflammation or ulceration in the surrounding soft tissue is detected in the visual examination of the relevant tooth, radiological evaluation will be made with periapical radiography. If the patient has a panoramic radiograph obtained in the last 6 months for different treatment needs, it will be used during the clinical examination. Otherwise, a periapical radiograph will be taken from the patient.
  • The clinical performance of the restoration will be evaluated with the FDI criteria. Where necessary, digital camera restoration images will be taken.
02

Conditions studied

  • Pulp Exposure, Dental

Browse trials for

Keywords

  • direct pulp capping,
  • calcium hydroxide liner
03

In context

Dental Pulp Exposure

31 studies on the registry are indexed under Dental Pulp Exposure; 5 are open to participants now.

Browse Dental Pulp Exposure studies →

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 368 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The population of the study group consists of a dentist's patients that have been treated with calcium hydroxide as direct pulp capping between 2011-2020.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Has to be one of the patients treated with calcium hydroxide as direct pulp capping

Exclusion criteria

Exclusion Criteria:

  • Patients (treated with calcium hydroxide as direct pulp capping) who will not be available for the recall appointment
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
190 participants (actual)
Patient registry
No

Interventions

  • DeviceRadiopaque Calcium Hydroxide Composition

    Treatment of exposed pulp tissue with radiopaque calcium hydroxide composition as a direct pulp capping material

06

What researchers measure

Primary outcomes

  1. Number of participants with pulp capping treatment-related adverse events as assessed by vitality tests and intra-oral examination

    Vitality tests (cold, electrical pulp test) and radiographical examination

    Time frame: up to 11 years

Secondary outcomes

  1. Evaluation of the restorations with FDI,World Dental Federation - clinical criteria for the evaluation of direct restorations.

    The restorations will be evaluated for biological, esthetic and functional parameters as clinically acceptalbe and nonacceptable.

    Time frame: up to 11 years

07

Study locations

1 site
  • Istanbul Medipol University, Dental School
    Istanbul, 34083, Turkey (Türkiye)
08

References and documents

Publications

  • Miles JP, Gluskin AH, Chambers D, Peters OA. Pulp capping with mineral trioxide aggregate (MTA): a retrospective analysis of carious pulp exposures treated by undergraduate dental students. Oper Dent. 2010 Jan-Feb;35(1):20-8. doi: 10.2341/09-038CR1. PubMed 20166407 ↗
  • Al-Hiyasat AS, Barrieshi-Nusair KM, Al-Omari MA. The radiographic outcomes of direct pulp-capping procedures performed by dental students: a retrospective study. J Am Dent Assoc. 2006 Dec;137(12):1699-705. doi: 10.14219/jada.archive.2006.0116. PubMed 17138715 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Mar 2024 to primary completion in Apr 2025, 13 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Aug 2024 → Apr 2025 and completion Oct 2024 → May 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 11, 2022
First posted
May 31, 2022
StartActual
Mar 15, 2024
Primary completionActual
Apr 30, 2025was Aug 2024
CompletionActual
May 10, 2025was Oct 2024
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 5, 2026
Primary completion
Aug 30, 2024→Apr 30, 2025 (actual)
Nov 5, 2026
Study completion
Oct 30, 2024→May 10, 2025 (actual)
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Enrolling by invitation→Completed
    Primary completion Aug 30, 2024→Apr 30, 2025 (now actual)
    Study completion Oct 30, 2024→May 10, 2025 (now actual)
    + 3 other changes: index terms, verification date and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05397964
Responsible party
Funda Ozturk Bozkurt (Assosciate Professor, Istanbul Medipol University Hospital) — Principal investigator
First posted
May 31, 2022
Start date
Mar 15, 2024
Primary completion
Apr 30, 2025
Completion
May 10, 2025
Last update
Nov 5, 2026

Study contacts

Funda Öztürk Bozkurt
principal investigator · fbozkurt@medipol.edu.tr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion